<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Adult congenital heart disease anatomic and physiologic classification</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Adult congenital heart disease anatomic and physiologic classification</h1>
<div class="graphic"><div class="figure"><div class="ttl">Adult congenital heart disease anatomic and physiologic classification</div><div class="cntnt"><table cellspacing="0" class="container"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="container"> <table cellspacing="0"> <tbody> <tr> <td class="subtitle1_single">CHD anatomy*</td> </tr> <tr> <td class="subtitle2_single">I: Simple</td> </tr> <tr> <td class="indent2">Native disease</td> </tr> <tr> <td class="indent3">Isolated small ASD</td> </tr> <tr> <td class="indent3">Isolated small VSD</td> </tr> <tr> <td class="indent3">Mild isolated pulmonic stenosis</td> </tr> <tr> <td class="indent2">Repaired conditions</td> </tr> <tr> <td class="indent3">Previously ligated or occluded ductus arteriosus</td> </tr> <tr> <td class="indent3">Repaired secundum ASD or sinus venosus defect without significant residual shunt or chamber enlargement</td> </tr> <tr class="divider_bottom"> <td class="indent3">Repaired VSD without significant residual shunt or chamber enlargement</td> </tr> <tr> <td class="subtitle2_single">II: Moderate complexity</td> </tr> <tr> <td class="indent2">Repaired or unrepaired conditions</td> </tr> <tr> <td class="indent3">Aorto-left ventricular fistula</td> </tr> <tr> <td class="indent3">Anomalous pulmonary venous connection, partial or total</td> </tr> <tr> <td class="indent3">Anomalous coronary artery arising from the pulmonary artery</td> </tr> <tr> <td class="indent3">Anomalous aortic origin of a coronary artery from the opposite sinus</td> </tr> <tr> <td class="indent3">AVSD (partial or complete, including primum ASD)</td> </tr> <tr> <td class="indent3">Congenital aortic valve disease</td> </tr> <tr> <td class="indent3">Congenital mitral valve disease</td> </tr> <tr> <td class="indent3">Coarctation of the aorta</td> </tr> <tr> <td class="indent3">Ebstein anomaly (disease spectrum includes mild, moderate, and severe variations)</td> </tr> <tr> <td class="indent3">Infundibular right ventricular outflow obstruction</td> </tr> <tr> <td class="indent3">Ostium primum ASD</td> </tr> <tr> <td class="indent3">Moderate and large unrepaired secundum ASD</td> </tr> <tr> <td class="indent3">Moderate and large persistently patent ductus arteriosus</td> </tr> <tr> <td class="indent3">Pulmonary valve regurgitation (moderate or greater)</td> </tr> <tr> <td class="indent3">Pulmonary valve stenosis (moderate or greater)</td> </tr> <tr> <td class="indent3">Peripheral pulmonary stenosis</td> </tr> <tr> <td class="indent3">Sinus of Valsalva fistula/aneurysm</td> </tr> <tr> <td class="indent3">Sinus venosus defect</td> </tr> <tr> <td class="indent3">Subvalvar aortic stenosis (excluding HCM; HCM not addressed in these guidelines)</td> </tr> <tr> <td class="indent3">Supravalvar aortic stenosis</td> </tr> <tr> <td class="indent3">Straddling atrioventricular valve</td> </tr> <tr> <td class="indent3">Repaired tetralogy of Fallot</td> </tr> <tr class="divider_bottom"> <td class="indent3">VSD with associated abnormality and/or moderate or greater shunt</td> </tr> <tr> <td class="subtitle2_single">III: Great complexity (or complex)</td> </tr> <tr> <td class="indent2">Cyanotic congenital heart defect (unrepaired or palliated, all forms)</td> </tr> <tr> <td class="indent2">Double-outlet ventricle</td> </tr> <tr> <td class="indent2">Fontan procedure</td> </tr> <tr> <td class="indent2">Interrupted aortic arch</td> </tr> <tr> <td class="indent2">Mitral atresia</td> </tr> <tr> <td class="indent2">Single ventricle (including double inlet left ventricle, tricuspid atresia, hypoplastic left heart, any other anatomic abnormality with a functionally single ventricle)</td> </tr> </tbody> </table> </td> <td class="container"> <table cellspacing="0"> <tbody> <tr> <td class="subtitle1_single">CHD anatomy* (continued)</td> </tr> <tr> <td class="subtitle2_single">III: Great complexity (or complex) (continued)</td> </tr> <tr> <td class="indent2">Pulmonary atresia (all forms)</td> </tr> <tr> <td class="indent2">TGA (classic or d-TGA; CCTGA or l-TGA)</td> </tr> <tr> <td class="indent2">Truncus arteriosus</td> </tr> <tr class="divider_bottom"> <td class="indent2">Other abnormalities of atrioventricular and ventriculoarterial connection (ie, crisscross heart, isomerism, heterotaxy syndromes, ventricular inversion)</td> </tr> <tr> <td class="subtitle2_single">Physiological stage</td> </tr> <tr> <td class="indent2">A</td> </tr> <tr> <td class="indent3">NYHA FC I symptoms</td> </tr> <tr> <td class="indent3">No hemodynamic or anatomic sequelae</td> </tr> <tr> <td class="indent3">No arrhythmias</td> </tr> <tr> <td class="indent3">Normal exercise capacity</td> </tr> <tr> <td class="indent3">Normal renal/hepatic/pulmonary function</td> </tr> <tr> <td class="indent2">B</td> </tr> <tr> <td class="indent3">NYHA FC II symptoms</td> </tr> <tr> <td class="indent3">Mild hemodynamic sequelae (mild aortic enlargement, mild ventricular enlargement, mild ventricular dysfunction)</td> </tr> <tr> <td class="indent3">Mild valvular disease</td> </tr> <tr> <td class="indent3">Trivial or small shunt (not hemodynamically significant)</td> </tr> <tr> <td class="indent3">Arrhythmia not requiring treatment</td> </tr> <tr> <td class="indent3">Abnormal objective cardiac limitation to exercise</td> </tr> <tr> <td class="indent2">C</td> </tr> <tr> <td class="indent3">NYHA FC III symptoms</td> </tr> <tr> <td class="indent3">Significant (moderate or greater) valvular disease; moderate or greater ventricular dysfunction (systemic, pulmonic, or both)</td> </tr> <tr> <td class="indent3">Moderate aortic enlargement</td> </tr> <tr> <td class="indent3">Venous or arterial stenosis</td> </tr> <tr> <td class="indent3">Mild or moderate hypoxemia/cyanosis</td> </tr> <tr> <td class="indent3">Hemodynamically significant shunt</td> </tr> <tr> <td class="indent3">Arrhythmias controlled with treatment</td> </tr> <tr> <td class="indent3">Pulmonary hypertension (less than severe)</td> </tr> <tr> <td class="indent3">End-organ dysfunction responsive to therapy</td> </tr> <tr> <td class="indent2">D</td> </tr> <tr> <td class="indent3">NYHA FC IV symptoms</td> </tr> <tr> <td class="indent3">Severe aortic enlargement</td> </tr> <tr> <td class="indent3">Arrhythmias refractory to treatment</td> </tr> <tr> <td class="indent3">Severe hypoxemia (almost always associated with cyanosis)</td> </tr> <tr> <td class="indent3">Severe pulmonary hypertension</td> </tr> <tr> <td class="indent3">Eisenmenger syndrome</td> </tr> <tr> <td class="indent3">Refractory end-organ dysfunction</td> </tr> </tbody> </table> </td> </tr> </tbody></table></div><div class="graphic_lgnd">This list is not meant to be comprehensive; other conditions may be important in individual patients.</div><div class="graphic_footnotes">CHD: congenital heart disease; 

	AP: anatomic and physiologic; 

	ASD: atrial septal defect; 

	VSD: ventricular septal defect; 

	AVSD: atrioventricular septal defect; 

	CCTGA: congenitally corrected transposition of the great arteries; 

	CHD: congenital heart disease; 

	d-TGA: dextro-transposition of the great arteries; 

	FC: functional class; 

	HCM: hypertrophic cardiomyopathy; 

	l-TGA: levo-transposition of the great arteries; 

	NYHA: New York Heart Association; 

	TGA: transposition of the great arteries.</div><div class="graphic_reference">Reproduced from: Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019; 73:e81. Table used with the permission of Elsevier Inc. All rights reserved.</div><div id="graphicVersion">Graphic 126173 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
